PMCB
PharmaCyte Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.45
+5.02%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-42.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Apr 2, 2026 | SCHECHTER JONATHAN · director | A-Award | 119,170 | $0.67 |
| Apr 2, 2026 | WALKER WAYNE REMELL · director | A-Award | 119,170 | $0.67 |
| Apr 2, 2026 | WEINSTEIN ROBERT · director | A-Award | 119,170 | $0.67 |
| Apr 2, 2026 | Abecassis Michael M · director | A-Award | 119,170 | $0.67 |
| Jan 7, 2026 | Silverman Joshua · director, officer: CEO and President | Purchase | 40,000 | $0.83 |
| Jan 7, 2026 | Silverman Joshua · director, officer: CEO and President | Purchase | 30,000 | $0.79 |
| Jan 7, 2026 | SCHECHTER JONATHAN · director | Purchase | 20,000 | $0.84 |
| Dec 12, 2025 | WALKER WAYNE REMELL · director | A-Award | 37,500 | $0.00 |
| Dec 12, 2025 | WALKER WAYNE REMELL · director | F-InKind | 16,875 | $1.02 |
| Dec 12, 2025 | Silverman Joshua · director, officer: CEO and President | A-Award | 575,000 | $0.00 |
| Dec 12, 2025 | Silverman Joshua · director, officer: CEO and President | F-InKind | 258,750 | $1.02 |
| Dec 12, 2025 | SCHECHTER JONATHAN · director | A-Award | 150,000 | $0.00 |
| Dec 12, 2025 | SCHECHTER JONATHAN · director | F-InKind | 67,500 | $1.02 |
| Dec 12, 2025 | SCHECHTER JONATHAN · director | A-Award | 63,233 | $1.22 |
| Dec 12, 2025 | Abecassis Michael M · director | A-Award | 63,233 | $1.22 |
| Dec 12, 2025 | Abecassis Michael M · director | A-Award | 37,500 | $0.00 |
| Dec 12, 2025 | Abecassis Michael M · director | F-InKind | 16,875 | $1.02 |
| Dec 12, 2025 | WALKER WAYNE REMELL · director | A-Award | 63,233 | $1.22 |
| Dec 12, 2025 | WEINSTEIN ROBERT · director | F-InKind | 33,750 | $1.02 |
| Dec 12, 2025 | WEINSTEIN ROBERT · director | A-Award | 63,233 | $1.22 |
| Dec 12, 2025 | WEINSTEIN ROBERT · director | A-Award | 75,000 | $0.00 |
| Jul 17, 2024 | Abecassis Michael M · director | A-Award | 38,009 | $2.12 |
| Jul 17, 2024 | SCHECHTER JONATHAN · director | A-Award | 38,009 | $2.12 |
| Jul 17, 2024 | WEINSTEIN ROBERT · director | A-Award | 38,009 | $2.12 |
| Jul 17, 2024 | WALKER WAYNE REMELL · director | A-Award | 38,009 | $2.12 |
| Nov 22, 2023 | SCHECHTER JONATHAN · director | A-Award | 61,248 | $2.18 |
| Nov 22, 2023 | Abecassis Michael M · director | A-Award | 61,248 | $2.18 |
| Nov 22, 2023 | WEINSTEIN ROBERT · director | A-Award | 61,248 | $2.18 |
| Nov 22, 2023 | WALKER WAYNE REMELL · director | A-Award | 61,248 | $2.18 |
| Nov 22, 2023 | Trujillo Carlos · director, officer: Chief Financial Officer | A-Award | 85,000 | $2.18 |
Institutional positioning
13F filings over the trailing two quarters
New 12Increased 12Reduced 17Sold out 5
| Filer | Action | Shares | Filed |
|---|---|---|---|
| CITADEL ADVISORS LLC | Increased | 519,747 | May 15, 2026 |
| CITADEL ADVISORS LLC | Reduced | 369,481 | Sep 2, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 195,660 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 124,247 | Aug 12, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 56,778 | Aug 13, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 56,500 | May 14, 2026 |
| XTX TOPCO LTD | Increased | 52,362 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 51,467 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New Position | 44,853 | Aug 14, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 37,987 | Aug 13, 2026 |
| VIRTU FINANCIAL LLC | New Position | 37,532 | May 14, 2026 |
| NORTHERN TRUST CORP | Unchanged | 35,601 | May 14, 2026 |
| XTX Topco Ltd | Reduced | 34,180 | Aug 14, 2026 |
| NORTHERN TRUST CORP | Reduced | 32,624 | Aug 13, 2026 |
| JANE STREET GROUP, LLC | Increased | 30,064 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Apr 2, 2026